Report ID: UCMIG35J2122
Report ID:
UCMIG35J2122 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
In 2021, the global market for artificial intelligence (AI) in life sciences marked a significant milestone by attaining a valuation of approximately US$ 1.3 billion. The trajectory for this market's growth is poised for substantial expansion, with projections indicating a robust increase to around US$ 6.7 billion by the year 2030. This anticipated growth is fueled by a compelling compound annual growth rate (CAGR) of 20%, which is projected to span the forecast period from 2022 to 2030. The convergence of AI and life sciences is revolutionizing drug discovery, genomics, diagnostics, and personalized medicine, among other areas. As industries recognize the potential of AI to accelerate research, enhance medical decision-making, and usher in a new era of precision healthcare, the market's trajectory underscores its pivotal role in shaping the future of life sciences and healthcare innovation on a global scale.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Life Sciences Tools & Services by segment aggregation, the contribution of the Life Sciences Tools & Services in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Artificial Intelligence (AI) in Life Sciences was estimated to be valued at US$ XX Mn in 2021.
The Artificial Intelligence (AI) in Life Sciences Market is estimated to grow at a CAGR of XX% by 2028.
The Artificial Intelligence (AI) in Life Sciences Market is segmented on the basis of Offering, Deployment, Application, Geography.
Based on region, the Artificial Intelligence (AI) in Life Sciences Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Artificial Intelligence (AI) in Life Sciences Market are , IBM Corporation , Atomwise, Inc. , Nuance Communications, Inc. , NuMedii, Inc. , AiCure LLC. , APIXIO, Inc. , Insilico Medicine, Inc. , Enlitic, Inc. , Sensely, Inc. , Zebra Medical Vision .
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35J2122